NRAS mutations are found in various cancers including melanoma (20–25%), lung cancer (1%), acute myeloid leukemia (10%) and cutaneous T-cell lymphoma patients (4%) [8–10]. This evidence concerns the gene NRAS and primary cutaneous T-cell non-Hodgkin lymphoma.